Strategies for Vaccination and Control of Apicomplexan Protozoan Parasites

DSpace/Manakin Repository

Search OPUS

Advanced Search


My Account

Show simple item record Wallach, M
dc.contributor.editor Mendez-Vilas, A 2012-10-12T03:37:36Z 2011-01
dc.identifier.citation Science against microbial pathogens: communicating current research and technological advances, 2011, 1, pp. 644 - 649
dc.identifier.isbn 978-84-939843-1-1
dc.identifier.other B2 en_US
dc.description.abstract Over the past several decades a great deal of effort has been invested in developing new control and vaccination strategies for apicomplexan protozoan parasites. These organisms are the cause of some of the most significant and harmful diseases in both humans and animals worldwide and include as examples; Plasmodium (malaria) and Cryptosporidium in humans, Toxoplasma in humans and animals, Babesia and Neospora in cattle, and Eimeria the cause of coccidiosis in animals (poultry, sheep, cattle, etc.). In spite of a great deal of progress made in understanding at the molecular level how these organisms invade, survive and transmit in their respective hosts, there has been a paucity of new vaccines commercially developed against these parasitic protozoa over the past few decades. In this chapter, we will discuss the types of strategies being developed to help control these parasites, which includes the development of live and subunit (both native and recombinant DNA based) vaccines, the search for and use of new or existing drugs (such as artemisinin combination therapy against malaria), as well as simpler management & hygiene strategies that can be employed to help alleviate the burden of parasitic diseases.
dc.format Jessica Robinson
dc.publisher Formatex Research Center
dc.title Strategies for Vaccination and Control of Apicomplexan Protozoan Parasites
dc.type Chapter
dc.description.version Published
dc.parent Science against microbial pathogens: communicating current research and technological advances
dc.journal.number en_US
dc.publocation Spain en_US
dc.identifier.startpage 644 en_US
dc.identifier.endpage 649 en_US SCI.Institute for Biotechnology of Infectious Diseases en_US
dc.conference Verified OK en_US
dc.for 060307 Host-Parasite Interactions
dc.personcode 021128
dc.percentage 100 en_US Host-Parasite Interactions en_US
dc.classification.type FOR-08 en_US
dc.edition 1 en_US
dc.custom en_US en_US
dc.location.activity en_US
dc.description.keywords Apicomplexan parasites; vaccines; drug targets; ecoimmunology; immunotolerance en_US
dc.description.keywords Science & Technology
dc.description.keywords Life Sciences & Biomedicine
dc.description.keywords Physical Sciences
dc.description.keywords Ecology
dc.description.keywords Geosciences, Multidisciplinary
dc.description.keywords Environmental Sciences & Ecology
dc.description.keywords Geology
dc.description.keywords ECOLOGY
dc.description.keywords SHARK BAY
dc.description.keywords BACTERIAL COMMUNITIES
dc.description.keywords FLOW-CYTOMETRY
dc.description.keywords CLIMATE-CHANGE
dc.description.keywords SP-NOV.
dc.description.keywords DIVERSITY
dc.description.keywords AUSTRALIA
dc.description.keywords COASTAL
dc.description.keywords MICROORGANISMS
dc.description.keywords STROMATOLITES
dc.description.keywords Apicomplexan parasites
dc.description.keywords vaccines
dc.description.keywords drug targets
dc.description.keywords ecoimmunology
dc.description.keywords immunotolerance
pubs.embargo.period Not known
pubs.organisational-group /University of Technology Sydney
pubs.organisational-group /University of Technology Sydney/Faculty of Science
pubs.organisational-group /University of Technology Sydney/Strength - i3
utslib.copyright.status Open Access 2015-04-15 12:23:47.074767+10
utslib.collection.history General (ID: 2)

Files in this item

This item appears in the following Collection(s)

Show simple item record